P53 has been shown to be transcriptionally activated on the ALKBH5 by binding to its promoter in pancreatic cancer, as supported by genome analysis, microarray verification, luciferase analysis, and bioinformatics prediction.27 The gene discussed is TP53; the disease is familial pancreatic carcinoma.